Download MendeleyX-ray and cryo-EM structures of inhibitor-bound cytochromebc1complexes for structure-based drug discovery.
Amporndanai, K., Johnson, R.M., O'Neill, P.M., Fishwick, C.W.G., Jamson, A.H., Rawson, S., Muench, S.P., Hasnain, S.S., Antonyuk, S.V.(2018) IUCrJ 5: 200-210
- PubMed: 29765610
- DOI: https://doi.org/10.1107/S2052252518001616
- Primary Citation of Related Structures:
5OKD, 6FO0, 6FO2, 6FO6 - PubMed Abstract:
Cytochrome bc 1 , a dimeric multi-subunit electron-transport protein embedded in the inner mitochondrial membrane, is a major drug target for the treatment and prevention of malaria and toxoplasmosis. Structural studies of cytochrome bc 1 from mammalian homologues co-crystallized with lead compounds have underpinned structure-based drug design to develop compounds with higher potency and selectivity. However, owing to the limited amount of cytochrome bc 1 that may be available from parasites, all efforts have been focused on homologous cytochrome bc 1 complexes from mammalian species, which has resulted in the failure of some drug candidates owing to toxicity in the host. Crystallographic studies of the native parasite proteins are not feasible owing to limited availability of the proteins. Here, it is demonstrated that cytochrome bc 1 is highly amenable to single-particle cryo-EM (which uses significantly less protein) by solving the apo and two inhibitor-bound structures to ∼4.1 Å resolution, revealing clear inhibitor density at the binding site. Therefore, cryo-EM is proposed as a viable alternative method for structure-based drug discovery using both host and parasite enzymes.
Organizational Affiliation:
Molecular Biophysics Group, Institute of Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool, Liverpool L69 7ZB, England.
